Effect of Yangqixue Qufengshi Recipe on rheumatoid arthritis model mice under different genetic backgrounds

Chinese Journal of Integrative Medicine

Volumn 12, Issue 1, 2006, Pages 46-49

  Li, Fen ^a   Wu, Hong ^a   Deng, Jun Wei ^a   Fan, Song Qing ^a   Tian, Jing ^a   Gao, Jie Sheng ^a   Zhu, Ya Hui ^b   Lu, Guang Xiu ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Collagen induced arthritis; HLA DR4; Rheumatoid arthritis; Transgenic mice; Yangqixue Qufengshi Recipe

Indexed keywords

ANTIRHEUMATIC AGENT; COLLAGEN ANTIBODY; UNCLASSIFIED DRUG; YANGQIXUE QUFENGSHI;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BONE EROSION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; MALE; MOUSE; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; COLLAGEN TYPE II; DRUGS, CHINESE HERBAL; HLA-DR4 ANTIGEN; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT;

EID: 33645540419     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02857430     Document Type: Article

References (5)

1. Wagner U, Kaltenhauser S, Sauer H, et al. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. Arthritis Rheum 1997;40(2): 341-351.
2. Li F, Wu H, Deng JW, et al. Study on susceptible gene of rheumatoid arthritis by transgenic animal. Chin J Rheumatol 1999;3(2): 75-79.
3. Wu H, Gao JS, Li M, et al. Relationship between frequency of rheumatoid arthritis patients expressing HLA-DR4 alleles and effect of combined DMARDs therapy. Chin J Rheumatol 2001;5(4): 213-215.
4. Deng JW, Wu H, You XK, et al. Construction and expression of HLA-DRα, DRB1 * 0401 transgenic mice model. Chin J Med Genet 1999;16(6): 360-363.
5. Williams PJ, Jones RH, Rademacher TW. Reduction in the incidence and severity of collagen-induced arthritis in DBA/1 using exogenous dehydroepiandrosterone. Arthritis Rheum 1997;40(5): 907-911.